Swiss National Bank’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $450K | Hold |
489,660
| – | – | ﹤0.01% | 2286 |
|
|
2025
Q4 | $627K | Buy |
489,660
+19,000
| +4% | +$25.5K | ﹤0.01% | 2266 |
|
|
2025
Q3 | $612K | Hold |
470,660
| – | – | ﹤0.01% | 2275 |
|
|
2025
Q2 | $565K | Buy |
470,660
+32,700
| +7% | +$36.2K | ﹤0.01% | 2297 |
|
|
2025
Q1 | $473K | Hold |
437,960
| – | – | ﹤0.01% | 2346 |
|
|
2024
Q4 | $766K | Sell |
437,960
-32,000
| -7% | -$59.6K | ﹤0.01% | 2311 |
|
|
2024
Q3 | $907K | Sell |
469,960
-18,900
| -4% | -$37K | ﹤0.01% | 2255 |
|
|
2024
Q2 | $865K | Buy |
488,860
+60,200
| +14% | +$147K | ﹤0.01% | 2233 |
|
|
2024
Q1 | $1.16M | Buy |
+428,660
| New | +$1.03M | ﹤0.01% | 2140 |
|
|
2022
Q2 | – | Sell |
-171,800
| Closed | -$617K | – | 2767 |
|
|
2022
Q1 | $617K | Buy |
171,800
+15,700
| +10% | +$54.2K | ﹤0.01% | 2552 |
|
|
2021
Q4 | $612K | Hold |
156,100
| – | – | ﹤0.01% | 2623 |
|
|
2021
Q3 | $1.03M | Hold |
156,100
| – | – | ﹤0.01% | 2425 |
|
|
2021
Q2 | $962K | Sell |
156,100
-13,200
| -8% | -$70.6K | ﹤0.01% | 2497 |
|
|
2021
Q1 | $765K | Buy |
169,300
+8,100
| +5% | +$44.5K | ﹤0.01% | 2405 |
|
|
2020
Q4 | $967K | Buy |
+161,200
| New | +$1.06M | ﹤0.01% | 2302 |
|
|
2020
Q2 | – | Sell |
-134,900
| Closed | -$343K | – | 2478 |
|
|
2020
Q1 | $343K | Buy |
134,900
+6,600
| +5% | +$21.7K | ﹤0.01% | 2311 |
|
|
2019
Q4 | $446K | Hold |
128,300
| – | – | ﹤0.01% | 2445 |
|
|
2019
Q3 | $594K | Hold |
128,300
| – | – | ﹤0.01% | 2293 |
|
|
2019
Q2 | $1.58M | Buy |
+128,300
| New | +$1.63M | ﹤0.01% | 1839 |
|
|
2016
Q4 | – | Sell |
-41,900
| Closed | -$336K | – | 2565 |
|
|
2016
Q3 | $336K | Hold |
41,900
| – | – | ﹤0.01% | 2459 |
|
|
2016
Q2 | $378K | Sell |
41,900
-3,600
| -8% | -$33.8K | ﹤0.01% | 2470 |
|
|
2016
Q1 | $354K | Buy |
45,500
+9,300
| +26% | +$67.1K | ﹤0.01% | 2442 |
|
|
2015
Q4 | $391K | Hold |
36,200
| – | – | ﹤0.01% | 2385 |
|
|
2015
Q3 | $294K | Buy |
36,200
+5,400
| +18% | +$85K | ﹤0.01% | 2407 |
|
|
2015
Q2 | $745K | Hold |
30,800
| – | – | ﹤0.01% | 1987 |
|
|
2015
Q1 | $1.3M | Buy |
30,800
+800
| +3% | +$31.6K | ﹤0.01% | 1595 |
|
|
2014
Q4 | $1.01M | Buy |
30,000
+800
| +3% | +$22.7K | ﹤0.01% | 1725 |
|
|
2014
Q3 | $715K | Buy |
29,200
+1,400
| +5% | +$39.4K | ﹤0.01% | 1861 |
|
|
2014
Q2 | $817K | Buy |
27,800
+2,200
| +9% | +$70.5K | ﹤0.01% | 1841 |
|
|
2014
Q1 | $1.13M | Buy |
25,600
+5,600
| +28% | +$246K | ﹤0.01% | 1633 |
|
|
2013
Q4 | $766K | Sell |
20,000
-4,000
| -17% | -$118K | ﹤0.01% | 1726 |
|
|
2013
Q3 | $527K | Hold |
24,000
| – | – | ﹤0.01% | 1905 |
|
|
2013
Q2 | $419K | Buy |
+24,000
| New | +$421K | ﹤0.01% | 2040 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Swiss National Bank's LAB Position: Q1 2026 in Review
Swiss National Bank held its Standard BioTools (LAB) position steady in Q1 2026 at 489,660 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.
Swiss National Bank first reported a position in LAB in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.58M in Q2 2019. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Swiss National Bank held 489,660 shares of Standard BioTools worth $450K as of Q1 2026.
- Swiss National Bank left its Standard BioTools share count unchanged in Q1 2026.
- Standard BioTools made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2286 holding.
- Swiss National Bank first reported a position in Standard BioTools in Q2 2013 and has held it in 33 quarters since.
- Swiss National Bank's Standard BioTools position peaked at $1.58M in Q2 2019.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.